MSBP1 Antibody

What is MSBP1 and why is it important in plant biology research?

MSBP1 (Membrane Steroid-Binding Protein 1) is a critical negative regulator in the brassinosteroid (BR) signaling pathway in plants. It functions by binding to brassinolide (BL) in vitro and interacting with the extracellular domain of BAK1 (BRI1-Associated Receptor Kinase 1) in vivo . MSBP1 plays a vital role in plant growth and development by modulating cell expansion and responses to environmental stimuli through its regulatory effects on BR signaling . The protein is primarily localized to the plasma membrane and endocytic vesicles, where it accelerates BAK1 endocytosis and subsequently suppresses BR signaling by shifting the equilibrium of BAK1 toward endosomes . Understanding MSBP1 function is essential for researchers investigating plant hormone signaling networks, growth regulation, and stress responses.

How do MSBP1 antibodies contribute to brassinosteroid signaling research?

MSBP1 antibodies serve as crucial tools for investigating BR signaling mechanisms by enabling:

• Detection and quantification of MSBP1 protein expression levels in different plant tissues or under various treatment conditions

• Immunoprecipitation experiments to study protein-protein interactions between MSBP1 and its partners (particularly BAK1)

• Immunolocalization studies to visualize the subcellular distribution of MSBP1 in plant cells

• Western blot analysis to monitor changes in MSBP1 abundance during developmental processes or stress responses

• Chromatin immunoprecipitation (ChIP) assays when studying transcription factors that may regulate MSBP1 expression

These applications help researchers understand how MSBP1 negatively regulates BR signaling by enhancing BAK1 endocytosis, which subsequently reduces interaction between BAK1 and BRI1 (Brassinosteroid Insensitive 1) .

What are the main types of MSBP1 antibodies available for research?

While the search results don't specifically detail commercial MSBP1 antibodies, based on standard research practices, the following types would likely be available:

• Polyclonal antibodies: Generated against purified MSBP1 protein or synthetic peptides derived from MSBP1 sequences, these provide broad epitope recognition but may have higher batch-to-batch variability

• Monoclonal antibodies: Produced from single B-cell clones, offering high specificity for particular MSBP1 epitopes and consistent performance across experiments

• Phospho-specific antibodies: Designed to detect specifically phosphorylated forms of MSBP1, useful for studying post-translational modifications

• Domain-specific antibodies: Targeting particular regions of MSBP1, such as its steroid-binding domain or membrane-association regions

Each antibody type offers distinct advantages depending on the experimental approach, with considerations for specificity, sensitivity, and cross-reactivity with homologous proteins in different plant species.

What are the optimal protocols for using MSBP1 antibodies in co-immunoprecipitation studies with BAK1?

Based on the research demonstrating MSBP1's interaction with BAK1's extracellular domain , the following methodological approach is recommended:

• Sample preparation:

  • Extract proteins from plant tissues using a mild detergent buffer (e.g., 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% Triton X-100, protease inhibitor cocktail)

  • Maintain protein integrity by keeping samples cold (4°C) throughout the procedure

• Immunoprecipitation procedure:

  • Pre-clear lysates with protein A/G beads to reduce non-specific binding

  • Incubate cleared lysates with anti-MSBP1 antibodies (typically 2-5 μg antibody per 500 μg protein)

  • Add protein A/G beads and incubate with gentle rotation (4°C, overnight)

  • Wash beads 4-5 times with washing buffer (similar to extraction buffer but with reduced detergent)

  • Elute proteins with sample buffer for SDS-PAGE

• Detection:

  • Perform Western blot analysis using anti-BAK1 antibodies to detect co-precipitated BAK1

  • Include appropriate controls: input sample, IgG control, and ideally a negative control from MSBP1 knockout/knockdown plants

Note that since MSBP1-BAK1 interaction occurs in a BL-independent manner , brassinolide treatment prior to extraction is not necessary to observe this interaction, which distinguishes it from the BRI1-BAK1 interaction.

How can researchers effectively use MSBP1 antibodies to study endocytosis mechanisms?

To investigate MSBP1's role in accelerating BAK1 endocytosis , researchers should consider the following methodological approach:

• Immunofluorescence microscopy:

  • Fix plant tissues with paraformaldehyde (typically 4%)

  • Perform cell wall digestion for better antibody penetration

  • Block with appropriate blocking solution (BSA or normal serum)

  • Incubate with anti-MSBP1 primary antibody, followed by fluorescently-labeled secondary antibody

  • Co-stain with endocytic markers (e.g., FM4-64) or with anti-BAK1 antibodies

  • Image using confocal microscopy to track co-localization in plasma membrane versus endosomal compartments

• Biochemical fractionation:

  • Separate plasma membrane and endosomal fractions using density gradient centrifugation

  • Analyze fractions by Western blotting with anti-MSBP1 and anti-BAK1 antibodies

  • Quantify the relative distribution of these proteins across fractions

• Live cell imaging with fluorescent protein fusions:

  • Complement antibody-based approaches with GFP-MSBP1 and RFP-BAK1 fusions

  • Validate localization patterns observed with antibodies

  • Perform photobleaching experiments (FRAP) to study dynamics

These approaches allow researchers to establish how MSBP1 promotes BAK1 internalization, which results in suppressed BR signaling by shifting the equilibrium of BAK1 toward endosomes .

What controls should be included when validating MSBP1 antibody specificity?

To ensure antibody specificity and reliability in MSBP1 research, include the following controls:

• Genetic controls:

  • MSBP1 knockout/knockdown plants - should show significantly reduced or absent signal

  • MSBP1 overexpression lines - should show enhanced signal intensity

• Peptide competition assay:

  • Pre-incubate antibody with excess immunizing peptide before application

  • Signal should be significantly reduced or eliminated

• Cross-reactivity assessment:

  • Test antibody against recombinant MSBP1 and related proteins (if available)

  • Evaluate potential cross-reactivity with MSBP1 homologs in the species of interest

• Multiple antibody validation:

  • Use antibodies generated against different MSBP1 epitopes

  • Compare staining patterns to confirm consistency

• Western blot molecular weight verification:

  • Confirm that the detected protein matches the predicted molecular weight of MSBP1

  • Look for potential post-translational modifications that might affect mobility

These validation steps are crucial since antibody specificity directly impacts the reliability of experimental findings regarding MSBP1's role in BR signaling regulation.

How can phosphorylation-specific antibodies be used to study MSBP1 regulation in BR signaling?

While the search results don't specifically mention phosphorylation of MSBP1, phosphorylation is a common regulatory mechanism in BR signaling pathways. Based on the detailed phosphorylation information about BRI1 , a methodological approach for investigating MSBP1 phosphorylation would include:

• Identification of potential phosphorylation sites:

  • Perform in silico analysis of MSBP1 sequence for putative phosphorylation motifs

  • Consider both Ser/Thr and Tyr phosphorylation sites based on the patterns observed in BRI1

  • Focus on residues in functional domains or protein interaction interfaces

• Generation of phospho-specific antibodies:

  • Design synthetic phosphopeptides corresponding to predicted sites

  • Generate and purify antibodies that specifically recognize phosphorylated forms

• Experimental validation:

  • Use phospho-specific antibodies in Western blots to detect phosphorylated MSBP1

  • Compare phosphorylation status under different conditions (±BR treatment)

  • Validate with phosphatase treatments as controls

• Functional characterization:

  • Generate MSBP1 phospho-mutants (Ser/Thr/Tyr to Ala or Asp/Glu)

  • Express these in msbp1 mutant backgrounds

  • Assess protein-protein interactions and BR signaling outputs

This approach would help determine whether phosphorylation regulates MSBP1's ability to interact with BAK1 and enhance its endocytosis, similar to how phosphorylation regulates other components of the BR signaling pathway .

What strategies can resolve contradictory findings when using MSBP1 antibodies in different experimental systems?

When faced with contradictory results using MSBP1 antibodies across different experimental systems, consider the following methodological approaches:

• Antibody validation across systems:

  • Re-validate antibody specificity in each system using the controls outlined in section 2.3

  • Consider epitope accessibility differences between methods (native vs. denatured proteins)

• System-specific factors:

  • Evaluate expression levels of MSBP1 homologs or isoforms in different systems

  • Consider tissue-specific or developmental differences in MSBP1 expression and localization

  • Assess potential post-translational modifications that might differ between systems

• Experimental design harmonization:

  • Standardize protein extraction methods across systems

  • Use consistent antibody concentrations and incubation conditions

  • Apply multiple detection methods (e.g., fluorescence and enzymatic)

• Complementary approaches:

  • Supplement antibody-based methods with genetic tools (RNAi, CRISPR)

  • Use epitope-tagged MSBP1 constructs as an alternative approach

  • Apply mass spectrometry for unbiased protein identification

• Statistical analysis:

  • Increase biological and technical replicates

  • Apply appropriate statistical tests to determine significance

  • Consider meta-analysis approaches when comparing across studies

These strategies help researchers distinguish genuine biological differences from technical artifacts when studying MSBP1's role in BR signaling regulation.

How can MSBP1 antibodies be used effectively in multiplex immunoassays to study BR signaling complexes?

To investigate the complex protein interactions in BR signaling involving MSBP1, BAK1, and BRI1 , researchers can employ multiplex immunoassays with the following methodological considerations:

• Antibody panel selection and validation:

  • Choose antibodies targeting MSBP1, BAK1, BRI1, and other BR pathway components

  • Ensure antibodies are raised in different host species to avoid cross-reactivity

  • Validate each antibody individually before multiplexing

• Multiplex immunoprecipitation approaches:

  • Sequential immunoprecipitation: First pull down with anti-MSBP1, then perform a second IP on the eluate with anti-BAK1

  • Analyze the final precipitate for the presence of BRI1 and other components

  • This can reveal whether MSBP1, BAK1, and BRI1 exist in the same complex

• Bead-based multiplex assays:

  • Conjugate different antibodies to distinguishable beads (e.g., different colors)

  • Incubate with plant protein extracts

  • Analyze using flow cytometry to quantify multiple protein-protein interactions simultaneously

• Proximity ligation assays (PLA):

  • Apply pairs of antibodies targeting different proteins (e.g., MSBP1+BAK1, BAK1+BRI1)

  • Generate fluorescent signals only when proteins are in close proximity (<40 nm)

  • Quantify interaction events using fluorescence microscopy

• Analysis and data integration:

  • Use appropriate controls for each antibody combination

  • Apply computational methods to integrate data from multiple antibody combinations

  • Create protein interaction networks based on quantitative multiplex data

These approaches can reveal how MSBP1 competes with BRI1 for BAK1 binding and how this competition is affected by BR treatment or other stimuli.

How can researchers address non-specific binding when using MSBP1 antibodies in plant tissues?

Non-specific binding is a common challenge when using antibodies in plant tissues. For MSBP1 antibodies, consider these methodological solutions:

• Optimization of blocking conditions:

  • Test different blocking agents (BSA, milk, normal serum, plant-specific blockers)

  • Extend blocking time (1-3 hours at room temperature or overnight at 4°C)

  • Add 0.1-0.3% Triton X-100 to reduce hydrophobic interactions

• Antibody dilution optimization:

  • Perform titration experiments to determine optimal antibody concentration

  • Typical range: 1:500 to 1:5000 for Western blots, 1:100 to 1:500 for immunofluorescence

  • Incubate longer at lower concentrations to improve signal-to-noise ratio

• Pre-adsorption techniques:

  • Incubate antibody with plant extract from msbp1 knockout plants

  • Remove antibodies that bind to non-MSBP1 proteins before use

• Modified extraction protocols:

  • Add reducing agents (DTT, β-mercaptoethanol) to minimize disulfide-mediated interactions

  • Include specific detergents (CHAPS, NP-40) that may preserve MSBP1 structure while reducing non-specific interactions

• Alternative detection systems:

  • Switch from chromogenic to chemiluminescent or fluorescent detection

  • Use secondary antibody fragments (Fab) instead of whole IgG molecules

These approaches can significantly improve the specificity of MSBP1 detection in complex plant samples, enabling more reliable localization and interaction studies.

What are the best approaches for optimizing MSBP1 antibody-based detection in different plant species?

When adapting MSBP1 antibody protocols across plant species, consider these methodological strategies:

• Sequence homology analysis:

  • Compare MSBP1 sequences between model organism (e.g., Arabidopsis) and target species

  • Identify regions of high conservation that might be recognized by existing antibodies

  • Focus on antibodies raised against conserved epitopes

• Species-specific protocol modifications:

  • Adjust extraction buffers based on species-specific characteristics:

    • For species with high phenolic compounds: Add PVPP (1-2%) and higher concentrations of reducing agents

    • For species with abundant secondary metabolites: Include specific absorbents (e.g., activated charcoal)

• Epitope retrieval optimization:

  • Test different antigen retrieval methods for fixed tissues

  • Adjust pH and temperature conditions based on species-specific tissue characteristics

• Validation approach:

  • Use heterologous expression systems to verify antibody cross-reactivity

  • Express the target species' MSBP1 in bacteria or yeast for antibody testing

  • Consider raising new antibodies against species-specific MSBP1 if conservation is low

• Data interpretation considerations:

  • Account for potential differences in MSBP1 function between species

  • Consider evolutionary divergence when interpreting localization or interaction data

  • Validate biological findings with genetic approaches when possible

This systematic approach helps researchers adapt MSBP1 antibody-based methods across plant species while maintaining reliability and specificity.

How should researchers interpret conflicting results between MSBP1 antibody staining and fluorescent protein fusion localization?

When facing discrepancies between antibody staining patterns and fluorescent protein fusions (e.g., GFP-MSBP1), consider these methodological approaches:

• Systematic comparison analysis:

  • Document specific differences in localization patterns

  • Quantify co-localization coefficients between both methods

  • Consider creating a table comparing results in different subcellular compartments:

  Subcellular Location	Anti-MSBP1 Antibody	GFP-MSBP1 Fusion	Possible Explanation
  Plasma membrane	+++	++	Antibody may detect additional MSBP1 isoforms
  Endosomes	+	+++	GFP tag might enhance endocytic trafficking
  ER	-	+	Overexpression artifact in fusion construct
  Nucleus	-	-	Neither method detects nuclear localization

• Technical considerations:

  • Antibody access limitations in certain compartments

  • GFP-fusion protein size (~27kDa addition) may alter trafficking

  • Fixation artifacts affecting epitope accessibility

  • Expression level differences between endogenous and fusion proteins

• Biological interpretation approaches:

  • Consider both methods as complementary rather than contradictory

  • Verify with additional approaches (biochemical fractionation)

  • Test multiple fusion orientations (N-terminal vs. C-terminal tags)

  • Use alternative fluorescent proteins with different properties

• Validation experiments:

  • Immunostain GFP-MSBP1 expressing tissues with anti-MSBP1 antibodies

  • Compare localization in different treatment conditions (±BR)

  • Examine temporal dynamics that might explain differences

These approaches help researchers reconcile differences between methods and develop more accurate models of MSBP1 localization and function in BR signaling regulation.

How can MSBP1 antibodies be adapted for super-resolution microscopy to study membrane nanodomain organization?

As research on BR signaling moves toward nanoscale organization, MSBP1 antibodies can be adapted for super-resolution microscopy with these methodological considerations:

• Antibody modification for super-resolution techniques:

  • Direct labeling with small organic fluorophores (Alexa Fluor 647, Atto 488) for STORM/PALM

  • Using Fab fragments or nanobodies for reduced linkage error

  • Site-specific labeling strategies to maintain antibody functionality

• Sample preparation optimization:

  • Thinner tissue sections (50-100 nm) or isolated membrane sheets

  • Special fixation protocols preserving membrane organization

  • Optimized clearing methods for plant tissues to reduce background

• Imaging approaches:

  • Single-molecule localization microscopy (STORM/PALM) for precise localization of MSBP1

  • Stimulated emission depletion (STED) microscopy for live-cell applications

  • Expansion microscopy to physically enlarge samples for conventional imaging

• Co-localization studies at nanoscale resolution:

  • Dual-color super-resolution to examine MSBP1-BAK1 interaction sites

  • Correlative light-electron microscopy to relate MSBP1 distribution to membrane structures

  • Quantitative cluster analysis of receptor distribution

• Data analysis considerations:

  • Specialized algorithms for nanocluster identification

  • Spatial statistics approaches (Ripley's K-function, pair correlation)

  • 3D reconstruction of membrane domains

These approaches would enable researchers to investigate whether MSBP1 and BAK1 co-localize in specific membrane nanodomains during BR signaling regulation, potentially revealing new mechanisms of MSBP1's negative regulatory function.

What methods combine MSBP1 antibodies with metabolomic approaches to link protein function to brassinosteroid metabolism?

To integrate MSBP1 protein studies with brassinosteroid metabolic analysis, researchers can employ these methodological strategies:

• Immunoprecipitation coupled with metabolite analysis:

  • Use anti-MSBP1 antibodies to pull down MSBP1 protein complexes

  • Extract bound small molecules (potential BR metabolites)

  • Analyze using LC-MS/MS to identify associated brassinosteroids

  • Compare metabolite profiles between wild-type and msbp1 mutant plants

• Proximity labeling approaches:

  • Generate MSBP1 fusions with promiscuous biotin ligases (BioID, TurboID)

  • Express in plants and activate labeling

  • Purify biotinylated proteins and metabolites

  • Identify BR-related enzymes and metabolites in MSBP1 proximity

• In situ metabolite imaging combined with immunolocalization:

  • Perform MSBP1 immunolocalization

  • Follow with mass spectrometry imaging on the same tissue section

  • Correlate MSBP1 protein distribution with local BR concentrations

• Integrative data analysis:

  • Create correlation networks between MSBP1 expression, localization, and BR metabolite levels

  • Apply multivariate statistical methods to identify significant associations

  • Develop predictive models of how MSBP1 affects BR homeostasis

This integrated approach would help researchers understand whether MSBP1's negative regulation of BR signaling involves direct effects on BR metabolism or is limited to signaling component interactions.

How can computational modeling be combined with MSBP1 antibody data to predict BR signaling dynamics?

To develop predictive models of BR signaling that incorporate MSBP1's regulatory role , researchers can integrate antibody-based experimental data with computational approaches:

• Quantitative data collection for model parameterization:

  • Use quantitative Western blots with MSBP1 antibodies to measure protein levels under various conditions

  • Apply phospho-specific antibodies to quantify phosphorylation state changes over time

  • Measure protein-protein interaction kinetics using surface plasmon resonance with purified components

• Spatial distribution mapping:

  • Quantify MSBP1, BAK1, and BRI1 distributions across cellular compartments using immunofluorescence

  • Track redistribution dynamics following BR treatment

  • Generate quantitative data on endocytosis rates using antibody-based endocytosis assays

• Mathematical modeling approaches:

  • Ordinary differential equation (ODE) models capturing protein interaction dynamics

  • Agent-based models simulating membrane protein behavior

  • Bayesian network models incorporating experimental uncertainty

• Model validation experiments:

  • Design experiments based on model predictions

  • Use MSBP1 antibodies to test model-predicted protein behavior

  • Iteratively refine models based on new experimental data

• Example prediction table from an integrated model:

  Perturbation	Predicted MSBP1-BAK1 Interaction	Predicted BR Response	Experimental Validation Method
  BL treatment	50% reduction within 30 min	3-fold increase in BES1 dephosphorylation	Co-IP with anti-MSBP1 + Western blot
  MSBP1 overexpression	2-fold increase in complex formation	60% reduction in BR-responsive gene expression	ChIP-qPCR with anti-BES1 antibodies
  BAK1 phospho-mutant	No change in binding but 70% reduction in endocytosis	Partial BR insensitivity	Immunofluorescence tracking of BAK1 internalization

This integrated approach would enable researchers to develop more accurate predictive models of how MSBP1 modulates BR signaling dynamics through its interaction with BAK1 and enhancement of BAK1 endocytosis.

What is the current consensus on MSBP1's role in BR signaling based on antibody-facilitated research?

Based on the search results and antibody-facilitated research, the current understanding of MSBP1's role in BR signaling can be summarized as follows:

• Mechanism of action: MSBP1 negatively regulates BR signaling by specifically interacting with the extracellular domain of BAK1 in a BL-independent manner . This interaction accelerates BAK1 endocytosis, shifting the equilibrium of BAK1 toward endosomes and away from plasma membrane-localized BRI1 .

• Functional impact: Enhanced MSBP1 expression reduces the interaction between BRI1 and BAK1 in vivo, demonstrating that MSBP1 acts as a negative factor at an early step of the BR signaling pathway . This suppression can be reversed by overexpressing BAK1 or its intracellular kinase domain .

• Ligand binding capacity: MSBP1 can bind to brassinolide (BL) in vitro , suggesting potential competition with BRI1 for ligand binding, although the BL-independent nature of the MSBP1-BAK1 interaction indicates that this may not be the primary regulatory mechanism.

• Subcellular dynamics: Both MSBP1 and BAK1 are localized to plasma membrane and endocytic vesicles , indicating a dynamic regulation of their localization that impacts signaling efficacy.

The consensus model positions MSBP1 as a key regulatory component that fine-tunes BR signaling by modulating the availability of the co-receptor BAK1 for interaction with the primary receptor BRI1, thereby affecting downstream BR-responsive processes including cell expansion and plant growth.

What are the most promising future directions for MSBP1 antibody applications in plant hormone cross-talk research?

Future research using MSBP1 antibodies should explore these promising directions:

• Hormone crosstalk mechanisms:

  • Investigate MSBP1's potential role in other hormone signaling pathways

  • Use antibodies to track MSBP1 complex formation under different hormone treatments

  • Explore whether MSBP1 interacts with other co-receptors besides BAK1, which is known to participate in multiple signaling pathways

• Environmental response integration:

  • Apply MSBP1 antibodies to study protein dynamics during stress responses

  • Investigate how environmental factors affect MSBP1-BAK1 interactions

  • Develop stress-specific antibodies that recognize stress-induced modifications of MSBP1

• Development of therapeutic applications:

  • Generate antibody-based tools to manipulate BR signaling in crop plants

  • Develop screening platforms using MSBP1 antibodies to identify compounds that modulate its activity

  • Engineer antibody fragments that can permeate plant cells to modulate MSBP1 function

• Technical innovations:

  • Create split-antibody complementation systems for in vivo monitoring of MSBP1-BAK1 interactions

  • Develop antibody-based biosensors for real-time tracking of BR signaling dynamics

  • Apply nanobody technology for improved imaging and manipulation of MSBP1 in living plants

These approaches would advance our understanding of how MSBP1 integrates various signaling pathways and environmental inputs to regulate plant growth and development, potentially leading to applications in agriculture and biotechnology.

How might emerging antibody engineering technologies improve MSBP1 research in the next decade?

Emerging antibody technologies will likely transform MSBP1 research through these methodological innovations:

• Single-domain antibodies and nanobodies:

  • Smaller size (15 kDa vs. 150 kDa for conventional antibodies) enabling better tissue penetration

  • Improved access to constrained epitopes in membrane protein complexes

  • Enhanced stability for in vivo applications and harsh extraction conditions

  • Potential for direct expression in plant cells as intrabodies to track or modulate MSBP1 function

• Recombinant antibody fragments with enhanced properties:

  • Site-specific conjugation for precise labeling

  • Engineered fragments with optimized plant tissue penetration

  • pH-responsive antibodies for compartment-specific binding

  • Temperature-stable variants for diverse experimental conditions

• Multi-specific antibodies:

  • Bispecific antibodies targeting both MSBP1 and BAK1 simultaneously

  • Trispecific constructs for studying complex formation with multiple components

  • Antibody arrays for high-throughput profiling of BR signaling complexes

• In vivo antibody expression systems:

  • Inducible expression of anti-MSBP1 antibody fragments in plants

  • Cell type-specific antibody expression for tissue-specific manipulation

  • Optogenetic control of antibody binding to enable temporal studies

• Integration with CRISPR technologies:

  • CRISPR-based epitope tagging of endogenous MSBP1

  • Antibody-guided CRISPR effectors for targeted manipulation of MSBP1 function

  • Combination of genetic and immunological approaches for validation